These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11136646)

  • 1. Occurrence of thrombocytopenia in psychiatric patients taking valproate.
    Trannel TJ; Ahmed I; Goebert D
    Am J Psychiatry; 2001 Jan; 158(1):128-30. PubMed ID: 11136646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocytosis associated with divalproex treatment.
    Tsivkin R; Saito E; Kafantaris V
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1011-4. PubMed ID: 16379522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions.
    Wassef AA; Winkler DE; Roache AL; Abobo VB; Lopez LM; Averill JP; Mian AI; Overall JE
    Am J Psychiatry; 2005 Feb; 162(2):330-9. PubMed ID: 15677599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
    Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
    Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder.
    De Berardis D; Campanella D; Matera V; Gambi F; La Rovere R; Sepede G; Grimaldi MR; Pacilli AM; Salerno RM; Ferro FM
    J Clin Psychopharmacol; 2003 Oct; 23(5):451-8. PubMed ID: 14520121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG; Lischetzki G; Trollmann R; Rascher W; Rauh M
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of valproate in an elderly population with affective symptoms.
    Kando JC; Tohen M; Castillo J; Zarate CA
    J Clin Psychiatry; 1996 Jun; 57(6):238-40. PubMed ID: 8666559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
    Buoli M; Serati M; Botturi A; Altamura AC
    Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses.
    Puryear LJ; Kunik ME; Workman R
    J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):234-7. PubMed ID: 8561838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.